The flexible chain: regulation of structure and activity of ETC complexes defines rate of ATP synthesis and sites of superoxide generation
Zhanna V. Bochkova,
No information about this author
А. А. Байжуманов,
No information about this author
A. I. Yusipovich
No information about this author
et al.
Biophysical Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 25, 2025
Language: Английский
Biomimetic peroxisome targets myocardial injury and promotes heart repair and regeneration
Ning Zhang,
No information about this author
Menghan Gao,
No information about this author
Xiaolong Hu
No information about this author
et al.
Biomaterials,
Journal Year:
2025,
Volume and Issue:
319, P. 123214 - 123214
Published: Feb. 25, 2025
Language: Английский
Cardiac Regeneration in Adult Zebrafish: A Review of Signaling and Metabolic Coordination
Current Cardiology Reports,
Journal Year:
2025,
Volume and Issue:
27(1)
Published: Jan. 10, 2025
Language: Английский
Targeting miRNA‐1a and miRNA‐15b: A Novel Combinatorial Strategy to Drive Adult Cardiac Regeneration
Ting Yuan,
No information about this author
Meiqian Wu,
No information about this author
Chaonan Zhu
No information about this author
et al.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 3, 2025
Despite
its
promise,
cardiac
regenerative
therapy
remains
clinically
elusive
due
to
the
difficulty
of
spatio-temporal
control
proliferative
induction,
and
need
coordinately
reprogram
multiple
regulatory
pathways
overcome
strict
post-mitotic
state
human
adult
cardiomyocytes.
To
address
this
unmet
therapeutic
need,
a
combinatorial
miRNA
interference
screen
is
performed
specifically
targeting
cardiac-predominant
miRNAs
regulating
key
aspects
cardiomyocyte
mitotic
induction
cell-cycle
completion
in
neonatal
rat
In
doing
so
miRNA-1a
miRNA-15b
(LNA-1a/15b)
identified
as
drivers
proliferation.
Due
miRNA-1a/15b
function
on
processes
modulating
mitosis,
inhibition
augmented
daughter
cell
formation,
improved
contractility
3D
organoids,
mouse
model
ST-segment
elevation
myocardial
infarction.
cardiac-restricted
pattern
expression,
strategy
provides
feasible
means
for
specific
with
minimal
risk
neoplasm
formation
off-target
toxicity.
The
approach
further
highlights
an
underutilized
simultaneous
co-regulation
disease
through
miRNAs.
Language: Английский
Activation of Mitochondria in Mesenchymal Stem Cells by Mitochondrial Delivery of Coenzyme Q<sub>10</sub>
Yuji Maruo,
No information about this author
Masahiro Shiraishi,
No information about this author
Mitsue Hibino
No information about this author
et al.
Biological and Pharmaceutical Bulletin,
Journal Year:
2024,
Volume and Issue:
47(8), P. 1415 - 1421
Published: Aug. 5, 2024
The
efficacy
of
mesenchymal
stem
cell
(MSC)
transplantation
has
been
reported
for
various
diseases.
We
previously
developed
a
drug
delivery
system
targeting
mitochondria
(MITO-Porter)
by
using
microfluidic
device
to
encapsulate
Coenzyme
Q10
(CoQ10)
on
large
scale.
current
study
aimed
confirm
if
treatment
with
CoQ10
encapsulated
MITO-Porter
enhanced
mitochondrial
functions
in
MSCs,
the
potential
improve
MSC
therapy.
used
highly
purified
human
bone
marrow-derived
described
as
rapidly
expanding
clones
(RECs),
and
attempted
control
increase
amount
system.
treated
these
RECs
MITO-Porter,
evaluated
its
cellular
uptake,
co-localization
mitochondria,
changes
respiratory
capacity,
toxicity.
There
was
no
significant
change
capacity
following
previous
MITO-Porter;
however,
significantly
increased
CoQ10-rich
MITO-Porter.
Utilization
enabled
be
controlled,
successfully
activated
MSCs.
thus
provides
promising
tool
Language: Английский
Transition from fetal to postnatal state in the heart: Crosstalk between metabolism and regeneration
Development Growth & Differentiation,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 27, 2024
Abstract
Cardiovascular
disease
is
the
leading
cause
of
mortality
worldwide.
Myocardial
injury
resulting
from
ischemia
can
be
fatal
because
limited
regenerative
capacity
adult
myocardium.
Mammalian
cardiomyocytes
rapidly
lose
their
proliferative
capacities,
with
only
a
small
fraction
myocardium
remaining
proliferative,
which
insufficient
to
support
post‐injury
recovery.
Recent
investigations
have
revealed
that
this
decline
in
myocardial
closely
linked
perinatal
metabolic
shifts.
Predominantly
glycolytic
fetal
metabolism
transitions
towards
mitochondrial
fatty
acid
oxidation
postnatally,
not
enables
efficient
production
ATP
but
also
causes
dramatic
reduction
cardiomyocyte
capacity.
Extensive
research
has
elucidated
mechanisms
behind
shift,
as
well
methods
modulate
these
pathways.
Some
been
successfully
applied
enhance
reprogramming
and
regeneration.
This
review
discusses
recently
acquired
insights
into
interplay
between
proliferation,
emphasizing
postnatal
transitions.
Language: Английский
Effects and mechanisms of the myocardial microenvironment on cardiomyocyte proliferation and regeneration
Kexiao Zheng,
No information about this author
Yanglin Hao,
No information about this author
Chenkun Xia
No information about this author
et al.
Frontiers in Cell and Developmental Biology,
Journal Year:
2024,
Volume and Issue:
12
Published: July 10, 2024
The
adult
mammalian
cardiomyocyte
has
a
limited
capacity
for
self-renewal,
which
leads
to
the
irreversible
heart
dysfunction
and
poses
significant
threat
myocardial
infarction
patients.
In
past
decades,
research
efforts
have
been
predominantly
concentrated
on
proliferation
regeneration.
However,
is
complex
organ
that
comprises
not
only
cardiomyocytes
but
also
numerous
noncardiomyocyte
cells,
all
playing
integral
roles
in
maintaining
cardiac
function.
addition,
are
exposed
dynamically
changing
physical
environment
includes
oxygen
saturation
mechanical
forces.
Recently,
growing
number
of
studies
microenvironment
regeneration
ongoing.
this
review,
we
provide
an
overview
recent
advances
microenvironment,
plays
important
role
Language: Английский
Advancing Human iPSC-Derived Cardiomyocyte Hypoxia Resistance for Cardiac Regenerative Therapies through a Systematic Assessment of In Vitro Conditioning
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(17), P. 9627 - 9627
Published: Sept. 5, 2024
Acute
myocardial
infarction
(MI)
is
a
sudden,
severe
cardiac
ischemic
event
that
results
in
the
death
of
up
to
one
billion
cardiomyocytes
(CMs)
and
subsequent
decrease
function.
Engineered
tissues
(ECTs)
are
promising
approach
deliver
necessary
mass
CMs
remuscularize
heart.
However,
hypoxic
environment
heart
post-MI
presents
critical
challenge
for
CM
engraftment.
Here,
we
present
high-throughput,
systematic
study
targeting
several
physiological
features
human
induced
pluripotent
stem
cell-derived
(hiPSC-CMs),
including
metabolism,
Wnt
signaling,
substrate,
heat
shock,
apoptosis,
mitochondrial
stabilization,
assess
their
efficacy
promoting
ischemia
resistance
hiPSC-CMs.
The
2D
experiments
identify
hypoxia
preconditioning
(HPC)
metabolic
conditioning
as
having
significant
influence
on
hiPSC-CM
function
normoxia
hypoxia.
Within
3D
engineered
(ECTs),
with
maturation
media
(MM),
featuring
high
fatty
acid
calcium
concentration,
1.5-fold
increase
active
stress
generation
compared
RPMI/B27
control
ECTs
normoxic
conditions.
Yet,
this
functional
improvement
lost
after
treatment.
Interestingly,
HPC
can
partially
rescue
MM-treated
Our
iterative
provides
strong
foundation
assessing
leveraging
vitro
culture
conditions
enhance
resistance,
thus
successful
clinical
translation,
hiPSC-CMs
regenerative
therapies.
Language: Английский
Combinatorial miRNA1a/15b interference drives adult cardiac regeneration
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 21, 2024
Abstract
BACKGROUND
Despite
its
promise,
cardiac
regenerative
therapy
remains
clinically
elusive
due
to
the
difficulty
of
spatio-temporal
control
proliferative
induction,
and
need
coordinately
reprogram
multiple
regulatory
pathways
overcome
strict
post-mitotic
state
human
adult
cardiomyocytes.
The
present
study
was
designed
identify
a
novel
combinatorial
miRNA
address
this
unmet
therapeutic
need.
METHODS
We
performed
interference
screen
specifically
targeting
cardiac-predominant
miRNAs
regulating
key
aspects
cardiomyocyte
mitotic
induction
cell-cycle
completion,
including
sarcomerogenesis,
metabolic
pathways.
Cardiomyocyte
proliferation
function
were
assessed
in
biopsies,
tissue
mimetics
mouse
disease
models.
RESULTS
identified
miR-1a
miR-15b
(LNA-1a/15b)
as
drivers
proliferation.
Due
miR-1a/15b
on
processes
modulating
mitosis,
inhibition
augmented
completion
daughter
cell
formation,
improved
contractility
vitro
2D
3D
ischemic
models,
model
ST-segment
elevation
myocardial
infarction
(STEMI).
cardiac-restricted
pattern
expression,
strategy
provides
feasible
for
specific
with
minimal
risk
neoplasm
formation
off-target
toxicity.
CONCLUSIONS
Combinatorial
drives
re-entry
cardiomyocytes
improves
response
infarction.
Our
data
LNA-based
anti-miR-1a/15b
attenuate
heart
failure
highlights
an
underutilized
simultaneous
co-regulation
through
interference.
Language: Английский
Engineered Cardiac Tissues as a Platform for CRISPR‐Based Mitogen Discovery
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 7, 2024
Improved
understanding
of
cardiomyocyte
(CM)
cell
cycle
regulation
may
allow
researchers
to
stimulate
pro-regenerative
effects
in
injured
hearts
or
promote
maturation
human
stem
cell-derived
CMs.
Gene
therapies,
particular,
hold
promise
induce
controlled
proliferation
endogenous
transplanted
CMs
via
transient
activation
mitogenic
processes.
Methods
identify
and
characterize
candidate
cardiac
mitogens
vitro
can
accelerate
translational
efforts
contribute
the
complex
regulatory
landscape
CM
postnatal
maturation.
In
this
study,
A
CRISPR
knockout-based
screening
strategy
using
neonatal
rat
ventricular
myocyte
(NRVM)
monolayers
is
established,
followed
by
mitogen
validation
mature
3-D
engineered
tissues
(ECTs).
This
screen
identified
knockout
purine
metabolism
enzyme
adenosine
deaminase
(ADA-KO)
as
an
effective
pro-mitogenic
stimulus.
RNA-sequencing
ECTs
further
reveals
increased
pentose
phosphate
pathway
(PPP)
activity
primary
driver
ADA-KO-induced
cycling.
Inhibition
pathway's
rate
limiting
enzyme,
glucose-6-phosphate
dehydrogenase
(G6PD),
prevented
ADA-KO
induced
cycling,
while
increasing
PPP
G6PD
overexpression
Together,
study
demonstrates
development
application
a
genetic/tissue
engineering
platform
for
discovery
new
affecting
regenerative
states
cardiomyocytes.
Language: Английский